Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Skin Neoplasms × Arsenic Trioxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 5 Multiple Myeloma 4 Neoplasms, Plasma Cell 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Leukemia, Promyelocytic, Acute 2 Leukemia, Myeloid, Acute 2 Blast Crisis 2 Skin Neoplasms 1 Oligodendroglioma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hodgkin Disease 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Basal Cell 1 Burkitt Lymphoma 1

Interventions

pembrolizumab 3 fludarabine 3 Cyclophosphamide 3 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 sargramostim 1 reolysin 1 poly ICLC 1 peginterferon alfa-2a 1 osimertinib 1 gusacitinib 1 fludarabine phosphate 1 eprenetapopt 1 dabrafenib 1 cobimetinib 1 cemiplimab 1 Vorinostat 1 Temozolomide 1 Radiotherapy 1 Radiation 1 Poly I-C 1 Nivolumab 1 Monatide (IMS 3015) 1 Methods 1 MAPRE1 protein, human 1 Ipilimumab 1 Interleukin-2 1 Interleukin-15 1 Interleukin-12 1 Histone Deacetylase Inhibitors 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01791894 2018-06-08

ATO

Stanford University

Phase 1/2 Completed

5 enrolled 9 charts

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡